{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:36:09Z","timestamp":1784860569555,"version":"3.55.0"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Malnutrition is a common complication of cancer treatment; it can affect energy levels and, as a consequence, quality of life. The goal of the current study was to evaluate the effect of dietetic intervention in a cohort of children treated for medulloblastoma and supratentorial primitive neuroectodermal tumors (PNET) over a 10\u2010year period.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>A retrospective chart review (1992\u20132002) of newly diagnosed cases of medulloblastoma\/supratentorial PNET was performed. Hospital records were reviewed for data, including demographic characteristics, patient heights and weights, and information on treatment modalities and the use of dietetic intervention. Percent changes in body weight were calculated at time points associated with particular stages of treatment or dietetic intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>One hundred three of 112 cases were evaluable. Treatment methods included surgery only (7.8%), surgery + radiotherapy (16.5%), surgery + chemotherapy (14.5%), and surgery + radiotherapy + chemotherapy (61.2%). There was no significant change in patient weight due to surgery (median change in body weight [MCBW], \u22120.35%) or radiotherapy (MCBW, \u22120.78%). In contrast, children experienced significant weight loss (MCBW, \u22124.35%; <jats:italic>P<\/jats:italic> &lt; 0.0001) 3 months after starting chemotherapy. A dietician saw 53 of the 103 children in the study cohort. There were 84 dietetic interventions (oral, 36%; parenteral, 27%; enteral, 37%) among these 53 patients. Oral diets did not result in weight gain. Parenteral nutrition was associated with significant weight gain at 1 month (MCBW, +2.7%; <jats:italic>P<\/jats:italic> = 0.03), but not at 3 months. The use of enteral feeds resulted in significant weight gain at 1 month (MCBW, +4.8%; <jats:italic>P<\/jats:italic> = 0.006) and at 3 months (MCBW, +11.8%; <jats:italic>P<\/jats:italic> &lt; 0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Current multimodality treatment of intracranial PNET results in significant nutritional morbidity, primarily due to the use of intensive chemotherapy regimens. Dietetic input for pediatric patients with medulloblastoma\/PNET is essential, and the implementation of enteral feeding in these children can help to reverse their nutritional morbidity. Cancer 2003;98:1014\u201320. \u00a9 2003 American Cancer Society.<\/jats:p><jats:p>DOI 10.1002\/cncr.11598<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.11598","type":"journal-article","created":{"date-parts":[[2003,8,22]],"date-time":"2003-08-22T09:26:36Z","timestamp":1061544396000},"page":"1014-1020","source":"Crossref","is-referenced-by-count":51,"title":["Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors"],"prefix":"10.1002","volume":"98","author":[{"given":"Jaimie","family":"Bakish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Hargrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nauman","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normand","family":"Laperriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"464","article-title":"Adjuvant chemotherapy for medulloblastoma: the first multi\u2010centre control trial of the International Society of Paediatric Oncology (SIOP I)","volume":"4","author":"Tait DM","year":"1990","journal-title":"Eur J Cancer."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1990.72.4.0572"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950250303"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","article-title":"Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized Phase III study","volume":"3","author":"Zeltzer PM","year":"1999","journal-title":"J Clin Oncol."},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.1999.17.7.2127","article-title":"Treatment of children with medulloblastomas with reduced\u2010dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study","volume":"7","author":"Packer RJ","year":"1999","journal-title":"J Clin Oncol."},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00071-0"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1200\/JCO.2001.19.10.2696","article-title":"Feasibility of four consecutive high\u2010dose chemotherapy cycles with stem\u2010cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study","volume":"10","author":"Strother D","year":"2001","journal-title":"J Clin Oncol."},{"key":"e_1_2_6_9_2","first-page":"61","article-title":"Quality of life, appetite, and weight change in patients receiving dose\u2010intensive chemotherapy","volume":"4","author":"Osoba D","year":"1994","journal-title":"Oncology (Huntingt)."},{"key":"e_1_2_6_10_2","volume-title":"Growth and development record, Tanner\u2013Whitehouse (1970)","author":"Tanner JM","year":"1984"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306173282401"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199408000-00007"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950250504"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(200003)34:3<177::AID-MPO3>3.0.CO;2-G"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/0148607190014003315"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(01)00632-3"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<119::AID-CNCR17>3.0.CO;2-X"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.1991.tb01798.x"},{"key":"e_1_2_6_19_2","first-page":"151","volume-title":"Pediatric manual of clinical dietetics","author":"Charuhas PM","year":"1998"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(97)00225-6"},{"key":"e_1_2_6_21_2","first-page":"479","volume-title":"Pediatric manual of clinical dietetics","author":"Klawitter BM","year":"1998"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199602000-00016"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1600589"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199903000-00006"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/jpon.2001.26875"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(95)70257-1"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/jpon.2002.126685"},{"key":"e_1_2_6_28_2","first-page":"431","article-title":"Supportive treatment in weight\u2010losing cancer patients due to the additive adverse effects of radiation treatment and\/or chemotherapy","volume":"19","author":"Erkurt E","year":"2000","journal-title":"J Exp Clin Cancer Res."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(96)00309-7"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-25268"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.11598","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.11598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:31:20Z","timestamp":1760297480000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.11598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1002\/cncr.11598"],"URL":"https:\/\/doi.org\/10.1002\/cncr.11598","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}